Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Return on Equity (2016 - 2025)

Avanos Medical's Return on Equity history spans 10 years, with the latest figure at 0.01% for Q3 2024.

  • For Q3 2024, Return on Equity rose 6.0% year-over-year to 0.01%; the TTM value through Sep 2024 reached 0.01%, up 6.0%, while the annual FY2023 figure was 0.04%, 6.0% down from the prior year.
  • Return on Equity for Q3 2024 was 0.01% at Avanos Medical, down from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.88% in Q2 2023 and bottomed at 0.1% in Q1 2024.
  • The 5-year median for Return on Equity is 0.0% (2020), against an average of 0.04%.
  • The largest annual shift saw Return on Equity surged 73bps in 2023 before it tumbled -88bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.02% in 2020, then dropped by -9bps to 0.02% in 2021, then soared by 198bps to 0.02% in 2022, then crashed by -274bps to 0.04% in 2023, then surged by 69bps to 0.01% in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Return on Equity are 0.01% (Q3 2024), 0.0% (Q2 2024), and 0.1% (Q1 2024).